TKO TOR Week ended 31 Jul 2026

Weekly Investor Report

Taseko Mines Limited · Basic Materials · Copper

Open interactive chart View report data
Latest close 9.46 CAD
-4.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -4.0% below the Trend Line and sits at 63.9% of its 52-week range. The latest completed week returned -4.3%, after a -4.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 55/100.

Setup score 47 out of 100
Latest Close 9.46 CAD 31 Jul 2026
1W Return -4.3% latest completed week
4W Return -4.4% short-term follow-through
12W Return -7.5% quarterly tape
Trend Breadth 96.2% 50 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -4.3% Latest completed week; four-week move -4.4%. Indicator stack 53/45 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 55/100 11 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -4.0% below the Trend Line and sits at 63.9% of its 52-week range. The latest completed week returned -4.3%, after a -4.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6012-week average 0.59

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.60Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.4% over four weeks, -7.5% over 12 weeks, and 122.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.3%
4W-4.4%
12W-7.5%
26W-8.6%
52W122.6%
Active trend streak0 weeks
Active weeks in one year50
Trend breadth96.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.35Latest activity-pressure read.
Pressure change19.4%Four-week change in activity pressure.
Leadership6.92Latest relative-leadership reading.
RS change-55.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 87%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength20/100Blend of value, momentum, and quality. Underlying universe rank 81; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality27/100Profitability and accounting quality. Underlying universe rank 74; rank 1 is best.
Momentum91/100Medium-term price momentum. Underlying universe rank 10; rank 1 is best.
Growth70/100Revenue and earnings growth. Underlying universe rank 31; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework24/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
235.7x
Price divided by trailing earnings.
Price / sales
4.7x
Market value relative to trailing revenue.
EV / EBITDA
19.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
28.1%
Gross profit retained from each unit of revenue.
Operating margin
22.3%
Operating profit retained from revenue.
Free-cash-flow margin
15.8%
Free cash flow generated from revenue.
Return on invested capital
9.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-53.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
-6.3%
Net share repurchases relative to market value.
Shareholder yield
-6.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 11 relevant articles.

3 positive · 8 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-24.1%Distance below the 52-week high.
13-week volatility7.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+12.9%Week of 12 Jun.
Worst week-19.4%Week of 6 Mar.
Latest week-4.3%Week of 31 Jul.

Shape of recent returns

Strong gains11
Modest gains2
Flat weeks0
Modest losses4
Sharp losses9
Recent vol7.8%13-week weekly-return volatility.
Base vol7.9%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew7.0% / -5.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape49/100

Trend, activity pressure, participation, and risk combine to a 49/100 tape read.

 Indicator analysis59/100

Latest 12-week confirmation: trend 10/12, activity pressure 0/12, relative leadership 12/12.

Activity pressure 0.60; No reversal markers Factors34/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 87; Small Cap Core rank 97 SVQF24/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 227.5 of 298 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment55/100

Weighted news tone is neutral across 11 relevant articles.

Shareholders of Taseko (NYSE: TGB) back Trekor Metals name change Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20269.46 CAD-4.3%9.85 CAD4.62 CAD-0.356.925.7MOff
24 Jul 20269.88 CAD3.9%9.79 CAD4.57 CAD-0.2312.186.6MOff
17 Jul 20269.51 CAD-7.8%9.72 CAD4.52 CAD-0.399.216.8MOn
10 Jul 202610.31 CAD4.1%9.65 CAD4.47 CAD-0.3819.275.5MOn
3 Jul 20269.90 CAD8.3%9.56 CAD4.42 CAD-0.4415.725.6MOn
26 Jun 20269.14 CAD-9.5%9.47 CAD4.37 CAD-0.708.671.3MOn
19 Jun 202610.10 CAD-3.5%9.41 CAD4.32 CAD-0.5921.12518.3KOn
12 Jun 202610.47 CAD12.9%9.28 CAD4.27 CAD-0.7227.132.0MOn
5 Jun 20269.27 CAD-9.6%9.13 CAD4.21 CAD-0.8515.641.4MOn
29 May 202610.25 CAD12.6%9.03 CAD4.17 CAD-0.6727.724.5MOn
22 May 20269.10 CAD-3.8%8.90 CAD4.11 CAD-0.7416.084.0MOn
15 May 20269.46 CAD-7.5%8.78 CAD4.06 CAD-0.6924.535.9MOn
8 May 202610.23 CAD5.1%8.65 CAD4.02 CAD-0.6635.696.8MOn
1 May 20269.73 CAD-1.1%8.51 CAD3.96 CAD-0.7231.944.1MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.